Eli Lilly & Co.
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
48.60%
Market Cap
947.01 Bil.
P/E Ratio
46.82
Dividend Yield
0.56 %
Earnings per Share
20.34 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1,005.6 G | 0 Units |
| PRICE DETERMINATION TIME | 07/15/2026 / 09:56:23 PM | |
| DAILY VOLUME (UNITS) | 46 | |
| DAILY HIGH / LOW | 1,011.6 | 995.1 |
| PREV. DAY'S PRICE | 1,014.2 | (07/14) |
| CHANGE DAY BEFORE | -8.60 | -0.85 % |
| 52 WEEK HIGH / LOW | 1,095 (06/29) | 537.5 (08/11) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 39.58 | 31.96 | 20.34 | 10.83 | 5.37 |
| DIVIDENDS PER SHARE | 6.76 | 6.07 | 5.32 | 4.81 | 4.18 |
| DIVIDEND YIELD IN % | - | - | 0.56 % | 0.67 % | 0.78 % |
| DIVIDEND GROWTH IN % | - | - | 10.63 % | 14.98 % | 12.16 % |
| PRICE - EARNINGS RATIO | 26.18 | 32.43 | 46.82 | 65.91 | 100.48 |
| PRICE - BOOK RATIO | - | - | 38.26 | 51.54 | 51.38 |
| PRICE - SALES RATIO | - | - | 14.83 | 15.49 | 15.43 |
| PRICE - CASH FLOW RATIO | - | - | 57.48 | 79.15 | 124.18 |
Master Data
| WKN | 858560 |
| ISIN | US5324571083 |
| SYMBOL | LLY |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Eli Lilly |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 941.74 Mil. |
| MARKET CAPITALISATION | 947.01 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| Performance | -6.32 % | 3.22 % | 29.74 % | 10.04 % | 48.60 % | 154.06 % | 407.99 % | 10.64 % |
| High | 1,087.00 | 1,095.00 | 1,095.00 | 1,095.00 | 1,095.00 | 1,095.00 | 1,095.00 | 1,095.00 |
| Low | 998.20 | 948.30 | 727.80 | 727.80 | 537.50 | 397.00 | 188.45 | 727.80 |
Eli Lilly does not deliver dividend information
Company profile
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.
Structured products for Eli Lilly & Co.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.